Robert Califf, FDA commissioner (Tom Williams/CQ Roll Call via AP Images)

FDA Com­mis­sion­er Robert Califf high­lights need for ‘cre­ative ap­proach­es’ for rare dis­ease ther­a­pies

The FDA’s top of­fi­cials con­tin­ue to call for new ways to reg­u­late up-and-com­ing med­i­cines for rare and ul­tra-rare dis­eases.

“We’re about to see a tsuna­mi …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.